Virtue
Carmot Therapeutics
Exploring Multiple Strategic Options: A Multi-Track Process
Sell-Side Forecast & Transaction Structuring Leading to Licensing Deal
Chris Parmentier, Virtue
“We have been working with RNA for several years. They are responsive, reliable, understand the nuances of our business and help us with modeling expertise that exceeds the capabilities within our corporate organization. We value them as an ecosystem partner and as a true extension of our operating team.”
Portfolio Modeling Supporting a Financing Transaction
Clinical-Stage Platform Therapeutics Company Needs Forecast, Modeling and Research Services to Support a Major Financing Transaction
Supporting the Entire Life Cycle: Biotech Company
RNA Advisors Supported a Biotech Company from Inception through IPO through M&A
Alex Mitchell, Dispatch Health
“I inherited the RNA team from the previous CFO and we’ve found them to be fantastic. They get healthcare, valuation, and they get the psychology of value just as much as the tools. They know how to get things done.”
M&A Valuation Support: Medical Device Company
Venture-backed Medical Device Company Needs to Assess Value From Different Perspectives
Doug Hughes, Neotrack
“The RNA team is great. Sam and Kayvon have done an exceptional job working with my companies for over a decade. They deliver on time and I don’t have to spend time getting them up to speed because they already know healthcare and medtech.”
Fairness Opinion: Distressed M&A
Private Company Under Financial Distress Considering Transaction Alternatives
